Ovarian cancer risk model needs a more meaningful clinical parameter

Affiliations

Comment

Francisco J Candido-dos-Reis. BMJ. 2014.

. 2014 Nov 18:349:g6689.

doi: 10.1136/bmj.g6689.

¹ Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, 14049-900 Brazil fjcreis@fmrp.usp.br.

No abstract available

Comment in

Authors' reply to Candido-dos-Reis.
Timmerman D, Kaijser J, Bourne T, Van Calster B. Timmerman D, et al. BMJ. 2014 Nov 18;349:g6691. doi: 10.1136/bmj.g6691. BMJ. 2014. PMID: 25406179 No abstract available.

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
Van Calster B, Van Hoorde K, Valentin L, Testa AC, Fischerova D, Van Holsbeke C, Savelli L, Franchi D, Epstein E, Kaijser J, Van Belle V, Czekierdowski A, Guerriero S, Fruscio R, Lanzani C, Scala F, Bourne T, Timmerman D; International Ovarian Tumour Analysis Group. Van Calster B, et al. BMJ. 2014 Oct 15;349:g5920. doi: 10.1136/bmj.g5920. BMJ. 2014. PMID: 25320247 Free PMC article.